Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

Biomet Inc, an Indiana, US corporation founded in 1977, is one of the largest orthopaedic medical device companies in the US and worldwide with operations in more than 50 locations throughout the world and distribution in approximately 90 countries. The company's principal subsidiaries include Biomet Orthopedics, Biomet Manufacturing, Biomet Europe, EBI, Biomet 3i, Biomet International, Biomet Microfixation, Biomet Sports Medicine and Biomet Biologics. Biomet and its subsidiaries design and manufacture products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy.

In September 2007, Biomet finalised its merger with LVB Acquisition Merger Sub Inc, a wholly-owned subsidiary of LVB Acquisition Inc, with Biomet being the surviving company of the merger. LVB Acquisition Inc is indirectly-owned by a consortium of private equity funds affiliated with The Blackstone Group, Goldman Sachs, Kohlberg Kravis Roberts and TPG Capital. This consortium, along with other investors, contributed US$5,387.5 million of equity in connection with the transaction. The remaining purchase price of US$6,245.4 million included various proceeds from credit facilities.

Prior to its merger with LVB Acquisition, Biomet had experienced an unsettled 18 months. It lost several of its board members and executives, had been involved in litigation with its shareholders and had to restate its financial results for certain periods following the discovery of stock option programme irregularities. Biomet had also previously been in merger talks with its competitor, Smith & Nephew, but this offer was rejected by Biomet.

In the year ended 31st May 2009, Biomet generated sales of US$2,504 million and employed approximately 7,100 people.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company's major competitors?
Key recent events in an at a glance format

Financial Review

Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus

Investigates the company's aims and its areas of focus

Products

Core product areas, key brands, product approvals and launches

Research and Development

How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution

Identifying the company's manufacturing locations
Sales and marketing facilities

Agreements

With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers and Acquisitions

Litigation

Key Corporate Events

Summary Operating Results
Overview
- Recent Key Events
Financial Review
- First Half Fiscal 2010 Financial Results
- Biomet - Quarterly Financial Results, Fiscal Years 2009-2010
- Biomet - Quarterly Sales by Geographic Area, Fiscal Years 2009-2010
- Biomet - Quarterly Revenues by Product Sector, Fiscal Years 2009-2010
- Reconstructive
- Fixation
- Spinal
- Other
- Fiscal 2009 Financial Results
- Biomet - Annual Financial Results, Fiscal Years 2005-2009
- Biomet - Annual Revenues and Operating Income/Loss, Fiscal Years 2005-2009
- Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
- Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
- Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
- Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
- Biomet - Five Year Financial Data
- Biomet - Five Year Financial Summary, Fiscal Years 2005-2009
- Employees
- Biomet Employees
Strategic Focus
Products
- Biomet - Fy2009 Revenues by Product Segment
- 2009 US Musculoskeletal Products Market
- Reconstructive Products
- 2009 US Orthopaedic Reconstructive Products Market
- Knee Systems
- Hip Systems
- Extremity Systems
- Dental Reconstructive Devices
- Other Reconstructive Products and Services
- Fixation Devices
- 2009 US Fixation Market
- Electrical Stimulation Systems
- External Fixation Devices
- Internal Fixation Devices
- Craniomaxillofacial Fixation Systems
- Bone Substitute M Aterials
- Spinal Products
- 2009 US Spinal Products Market
- Spine Fusion Stimulation Systems
- Spinal Fixation Systems
- Minimally-Invasive Spine Surgery
- Vertebral Body Compression Fracture
- Bone Substitute and Allograft M Aterials
- Precision M Achined Allograft
- ©espicom Business January 2010 Intelligence
- Biomet Table of Contents
- Motion Preservation Products
- Other Products
- Arthroscopy Products
- Orthopaedic Support Products
- Biomet - 2009 Fda Approvals
Research and Development
- Biomet - Annual R&D Expenditure
- Clinical Research Support
- Oncor
- Oref
Manufacturing and Distribution
- Biomet's Principal Manufacturing and Distribution Facilities, May 2009
Agreeme Nts
- Agreements Summary
- Kensey Nash
- Artimplant
- Materialise Dental
- Collagen M Atrix
- Marc T Ec
- Aap I Mplantate
- Cytomedix
- Brainlab
- Thermogenesis
- Diamicron
- Ceramtec
- Ossacur
- Pro-Dex
- Z-Kat
- Organogenesis
- Fermentech
- Btg
Me Rgers and Acquisitions
- Mergers and Acquisitions Summary
- Cartilix
- Zhejiang Biomet M Edical Products
- Interpore Cross I Nternational
- Merck's I Nterest in Biomet M Erck
- Biolectron
- Biogran Dental Grafting Product Line
- Implant I Nnovations I Nternational (3i)
- Kirschner
- Walter Lorenz Surgical I Nstruments
- Electro-Biology
- Orthopaedic E Quipment Company
Litigation
- US Department of Justice Consulting Agreement I Nvestigation
- US Department of Justice E Bi Products I Nvestigations and O Ther M Atters
- US Securities and E Xchange Commission I Nformal I Nvestigation
- Massachusetts Ag
- New Jersey Ag
- Heraeus Kulzer
- Zimmer US
- Dr John King
Key Corporate Events
- Index of Tables
  - Summary Operating Results.Iii
  - Recent Key Events
  - Biomet - Quarterly Financial Results, Fiscal Years 2009-2010
  - Biomet - Quarterly Sales by Geographic Area, Fiscal Years 2009-2010
  - Biomet - Quarterly Revenues by Product Sector, Fiscal Years 2009-2010
  - Biomet - Annual Financial Results, Fiscal Years 2005-2009
  - Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
  - Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
  - Biomet - Five Year Financial Summary, Fiscal Years 2005-2009
  - Biomet Employees
  - Biomet - 2009 Fda Approvals
  - Biomet - Annual R&D Expenditure
  - Biomet's Principal Manufacturing and Distribution Facilities, May 2009
  - Agreements Summary
  - Mergers and Acquisitions Summary
- Index of Charts
  - Biomet - Annual Revenues and Operating Income/Loss, Fiscal Years 2005-2009
  - Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
  - Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
  - Biomet - Fy2009 Revenues by Product Segment
  - 2009 US Musculoskeletal Products Market
  - 2009 US Orthopaedic Reconstructive Products Market
  - 2009 US Fixation Market
  - 2009 US Spinal Products Market

Pharmaceutical Market Research

Biomet Medical Device Company Intelligence Report